As shown in Table 2, high mRNA expression of PRDX1 showed a null association with OS or PFS among all ovarian cancer patients, serous ovarian cancer patients, and endometrioid ovarian cancer patients. This evidence concerns the gene PRDX1 and ovarian serous adenocarcinoma.